About this item:

118 Views | 64 Downloads

Author Notes:

Correspondence: edward.parker@imperial.ac.uk

The authors are grateful to R Sarkar for his help during the planning of this review.

Disclosures: EPK Parker has received funding from the UK Medical Research Council. M Iturriza-Gómara has received research grant support form GlaxoSmithKline and Sanofi Pasteur MSD.

The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties

Subjects:

Research Funding:

None declared

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Microbiology
  • cholera
  • enteropathy
  • histo blood group antigens
  • immunogenicity
  • malnutrition
  • microbiota
  • oral vaccines
  • poliovirus
  • rotavirus
  • Human rotavirus vaccine
  • Randomized controlled trial
  • Placebo-controlled trial
  • Vitamin-A supplements
  • Live cholera vaccine
  • Blood-group antigens
  • Killed bivalent 01
  • Breast-fed
  • 1st two years
  • Poliovirus vaccine

Causes of impaired oral vaccine efficacy in developing countries

Tools:

Journal Title:

Future Microbiology

Volume:

Volume 13, Number 1

Publisher:

, Pages 97-118

Type of Work:

Article | Final Publisher PDF

Abstract:

Oral vaccines are less immunogenic when given to infants in low-income compared with high-income countries, limiting their potential public health impact. Here, we review factors that might contribute to this phenomenon, including transplacental antibodies, breastfeeding, histo blood group antigens, enteric pathogens, malnutrition, microbiota dysbiosis and environmental enteropathy. We highlight several clear risk factors for vaccine failure, such as the inhibitory effect of enteroviruses on oral poliovirus vaccine. We also highlight the ambiguous and at times contradictory nature of the available evidence, which undoubtedly reflects the complex and interconnected nature of the factors involved. Mechanisms responsible for diminished immunogenicity may be specific to each oral vaccine. Interventions aiming to improve vaccine performance may need to reflect the diversity of these mechanisms.

Copyright information:

© 2017 Edward Parker.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Export to EndNote